Itron, Inc. (NASDAQ:ITRI) Receives $119.67 Consensus Target Price from Analysts

Shares of Itron, Inc. (NASDAQ:ITRI) have received a consensus rating of “Moderate Buy” from the thirteen ratings firms that are presently covering the company, Marketbeat Ratings reports. Four research analysts have rated the stock with a hold rating and nine have given a buy rating to the company. The average 12 month target price among brokers that have covered the stock in the last year is $119.67.

Several brokerages have issued reports on ITRI. Robert W. Baird boosted their target price on Itron from $115.00 to $123.00 and gave the company an “outperform” rating in a research note on Friday, August 2nd. Canaccord Genuity Group boosted their target price on Itron from $115.00 to $120.00 and gave the company a “buy” rating in a research note on Thursday, June 20th. BNP Paribas assumed coverage on Itron in a research note on Thursday, September 5th. They issued an “outperform” rating and a $133.00 target price on the stock. Janney Montgomery Scott assumed coverage on Itron in a research note on Friday, September 27th. They set a “buy” rating and a $131.00 price objective on the stock. Finally, Oppenheimer boosted their price objective on Itron from $110.00 to $112.00 and gave the company an “outperform” rating in a research note on Wednesday, July 17th.

Insider Activity

In other news, CEO Thomas Deitrich sold 887 shares of the stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $102.15, for a total transaction of $90,607.05. Following the transaction, the chief executive officer now directly owns 205,276 shares in the company, valued at approximately $20,968,943.40. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In related news, CEO Thomas Deitrich sold 887 shares of the firm’s stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $102.15, for a total transaction of $90,607.05. Following the transaction, the chief executive officer now directly owns 205,276 shares in the company, valued at $20,968,943.40. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Donald L. Reeves III sold 4,210 shares of the firm’s stock in a transaction that occurred on Thursday, August 22nd. The stock was sold at an average price of $101.00, for a total value of $425,210.00. Following the transaction, the senior vice president now owns 16,269 shares in the company, valued at approximately $1,643,169. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 43,276 shares of company stock worth $4,515,846. 1.45% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Itron

Institutional investors and hedge funds have recently bought and sold shares of the stock. Creative Planning lifted its holdings in Itron by 17.1% in the 3rd quarter. Creative Planning now owns 15,677 shares of the scientific and technical instruments company’s stock worth $1,674,000 after buying an additional 2,284 shares during the period. Oliver Luxxe Assets LLC lifted its holdings in Itron by 163.1% in the 3rd quarter. Oliver Luxxe Assets LLC now owns 22,488 shares of the scientific and technical instruments company’s stock worth $2,402,000 after buying an additional 13,942 shares during the period. Inspire Investing LLC lifted its holdings in Itron by 3.5% in the 3rd quarter. Inspire Investing LLC now owns 12,391 shares of the scientific and technical instruments company’s stock worth $1,323,000 after buying an additional 421 shares during the period. Perpetual Ltd lifted its holdings in Itron by 10.1% in the 3rd quarter. Perpetual Ltd now owns 88,126 shares of the scientific and technical instruments company’s stock worth $9,413,000 after buying an additional 8,102 shares during the period. Finally, CWM LLC lifted its holdings in Itron by 150.1% in the 3rd quarter. CWM LLC now owns 2,203 shares of the scientific and technical instruments company’s stock worth $235,000 after buying an additional 1,322 shares during the period. 96.19% of the stock is currently owned by institutional investors.

Itron Stock Performance

Shares of Itron stock opened at $110.06 on Friday. The business’s fifty day simple moving average is $101.74 and its 200 day simple moving average is $101.30. The firm has a market capitalization of $5.05 billion, a P/E ratio of 31.63, a price-to-earnings-growth ratio of 0.91 and a beta of 1.47. Itron has a 12 month low of $56.11 and a 12 month high of $113.07. The company has a current ratio of 3.16, a quick ratio of 2.61 and a debt-to-equity ratio of 0.98.

Itron (NASDAQ:ITRI) last issued its quarterly earnings results on Thursday, August 1st. The scientific and technical instruments company reported $1.21 EPS for the quarter, topping analysts’ consensus estimates of $0.96 by $0.25. The business had revenue of $609.07 million for the quarter, compared to analyst estimates of $599.25 million. Itron had a return on equity of 16.42% and a net margin of 7.98%. Itron’s quarterly revenue was up 12.6% compared to the same quarter last year. During the same period last year, the company posted $0.65 earnings per share. As a group, analysts anticipate that Itron will post 4.58 EPS for the current year.

About Itron

Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.